Hikma intros phenylephrine HCl Injection
Phenylephrine HCl Injection is indicated for increasing blood pressure in adults with hypotension resulting primarily from vasodilation in the setting of anesthesia.
Hikma is offering Phenylephrine HCl Injection, in 500 mcg/5 ml and 1,000 mcg/10 ml doses.
The product has been launched in the United States in ready-to-use vials.
It is indicated for increasing blood pressure in adults with clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia.
[Read more: Hikma intros Kloxxado]
Hikma will be marketing this product under the name Immphentiv and is introducing the first FDA approved 1,000 mcg/10 ml presentation to the U.S. market, broadening the choice of medicines available to hospitals.
[Read more: Hikma to acquire Custopharm]